Financial
FY2025 revenue ¥500.0bn (-1.7%); operating margin 10.4%; net income ¥35.5bn.
Balance sheet figures not captured from release.
Sysmex
HQ Japan · Asia-Pacific
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
At a glance
Financial health
Band: Strong
Customer rating
No reviews yet
Financial health
Band: StrongListed: 6869.T
FY2025 revenue ¥500.0bn (-1.7%); operating margin 10.4%; net income ¥35.5bn.
Balance sheet figures not captured from release.
Source: official results release · Year ended 2026-03-31 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
| Year | Revenue | Growth | Operating profit | Net income | Covers |
|---|---|---|---|---|---|
| FY2025 | JP¥500bn | -1.7% | JP¥51.8bn | JP¥35.5bn | Sysmex |
Products & services
Products not yet catalogued.
Risk summary
Full risk page with sources →Researched 8 Nov 2026
Adverse media
Not yet researched.
Cyber & information governance
Not yet researched.
Regulatory & clinical safety
Not yet researched.
Contract performance
Not yet researched.
Competitors
No competitors linked yet.